Continuous positive airway pressure (CPAP) therapy is often prescribed for sleep apnea, a condition characterized by pauses in breathing during sleep. Supplemental oxygen, delivered via an oxygen concentrator, can be integrated with CPAP therapy for individuals experiencing both sleep apnea and low blood oxygen levels (hypoxemia). This integrated approach combines the airway pressure maintenance of CPAP with the oxygen enrichment provided by the concentrator, ensuring adequate oxygenation during sleep and potentially improving overall treatment outcomes.
Combining these therapies addresses a significant clinical need, as untreated sleep apnea and hypoxemia can lead to serious health complications, including cardiovascular issues and cognitive impairment. This combined therapy has become increasingly important in managing complex respiratory conditions, especially in patients with comorbidities. Advancements in technology have led to smaller, more portable, and user-friendly devices, improving patient comfort and adherence to therapy.
